One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-146570
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 10 |
Affiliation: The Maria Sklodowska-Curie National Research Institute of Oncology, Medical University of Lublin, University Hospital Hradec Králové, National Cancer Institute, University of Debrecen, Hospital Universitario 12 De Octubre, University of New Brunswick, Geelong Hospital, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, The Royal Wolverhampton NHS Trust, Nebraska Hematology-Oncology, Gachon University Gil Medical Center, AstraZeneca (United States), Vita-Salute San Raffaele UniversityThree-Year Follow-up of the Ascend Trial: Acalabrutinib Vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
